In vitro inhibition of catalase activity by cigarette smoke: Relevance for oxidative stress

Journal of Applied Toxicology

Volumn 18, Issue 6, 1998, Pages 443-448

  Méndez Álvarez, Estefanía ^a   Soto Otero, Ramón ^a   Sánchez Sellero, Inés ^a   Lamas, Manuel López Rivadulla ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Bright tobacco; Burley tobacco; Catalase inhibition; Cigarette smoke; Hydrogen peroxide; Oxidative stress

Indexed keywords

CATALASE; CIGARETTE SMOKE; FREE RADICAL; ORGANIC SOLVENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL DAMAGE; CONTROLLED STUDY; CYTOTOXICITY; DIALYSIS; ENZYME INHIBITION; LIVER; MALE; MOLECULAR WEIGHT; MUTAGENIC ACTIVITY; MUTAGENICITY; NONHUMAN; OXIDATIVE STRESS; POLAROGRAPHY; PRIORITY JOURNAL; RAT; TIME;

ANIMALIA; NICOTIANA TABACUM;

EID: 0031781412     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(199811/12)18:6<443::AID-JAT530>3.0.CO;2-P     Document Type: Article

References (32)

1. L. B. Clerch, A 3′ untranslated region of catalase mRNA composed of a stem-loop and dinucleotide repeat elements binds a 69-kDa redox-sensitive protein. Arch. Biochem. Biophys. 317, 267-274 (1995).
2. C. de Duve, Biochemical studies on the occurrence, biogenesis and life history of mammalian peroxisomes. J. Histochem. Cytochem. 21, 941-948 (1973).
3. G. L. Gaunt and C. DeDuve, Subcellular distribution of D-amino acid oxidase and catalase in rat brain. J. Neurochem. 26, 749-759 (1976).
4. O. McKenna, G. Arnold and E. Holtzmann, Microperoxisome distribution in the central nervous system. Brain Res. 117, 181-194 (1976).
5. F. E. Pontieri, G. Tanda, F. Orzi and G. Di Chiara, Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature (London) 382, 255-257 (1996).
6. J. S. Fowler, N. D. Volkow, G.-J. Wang, N. Pappas, J. Logan, R. MacGregor, D. Alexoff, C. Shea, D. Schlyer, A.P. Wolf, D. Warner, I. Zezulkova and R. Cilento, Inhibition of monoamine oxidase B in the brains of smokers, Nature (London) 379, 733-736 (1996).
7. W. A. Pryor, B. J. Hales, P. I. Premovic and D. F. Church, The radicals in cigarette tar: their nature and suggested physiological implications. Science 220, 425-427 (1983).
8. J. Hobson, J. Wright and A. Churg, Histochemical evidence for generation of active oxygen species on the apical surface of cigarette-smoke-exposed tracheal explants. Am. J. Pathol. 139, 573-580 (1991).
9. A. Churg and K. Cherukupalli, Cigarette smoke causes rapid lipid peroxidation of rat tracheal epithelium. Int. J. Exp. Pathol. 74, 127-132 (1993).
10. G. W. Winston, D. F. Church, R. Cueto and W. A. Pryor, Oxygen consumption and oxyradical production from microsomal reduction of aqueous extracts of cigarette tar. Arch. Biochem. Biophys. 304, 371-378 (1993).
11. R. Anderson, Assessment of the roles of vitamin C, vitamin E, and beta-carotene in the modulation of oxidant stress mediated by cigarette smoke activated phagocytes. Am. J. Clin. Nutr. 53, 358-361 (1991).
12. G. Schectrnan, Estimating ascorbic acid requirements for cigarette smokers. Ann. NY Acad. Sci. 686, 335-346 (1993).
13. A. Mezzetti, D. Lapenna, S. D. Pierdomenico, A. M. Calafiore, F. Constantini, G. Riariosforza, T. Imbastaro, M. Neri and F. Cuccurullo, Vitamin E, and C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. Atherosclerosis 112, 91-99 (1995).
14. D. D. M. Wayner, G. W. Burton, K. U. Ingold, L. R. C. Barclay and S. J. Locke, The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical trapping antioxidant activity of human blood plasma. Biochim. Biophys. Acta 924, 408-419 (1987).
15. M. D. Nefzger, F. A. Quadfasel and V. C. Karl, A retrospective study of smoking in Parkinson's disease. Am. J. Epidemiol. 88, 149-158 (1968).
16. I. I. Kessler and E. C. Diamond, Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: a survey and explanatory hypothesis. Am. J. Epidemiol. 94, 16-25 (1971).
17. J. A. Baron, Cigarette smoking and Parkinson's disease. Neurology 36, 1490-1496 (1986).
18. W. Hellenbrand, A. Seidler, B.-P. Robra, P. Vieregge, W. H. Oertel, J. Joerg, P. Nischan, E. Schneider and G. Ulm, Smoking and Parkinson's disease: a case-control study in Germany. Int. J. Epidemiol. 26, 328-339 (1997).
19. P. Jenner and C.W. Olanow, Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders. In Neurodegeneration and Neuroprotection in Parkinson's Disease, ed. by C. W. Olanow, P. Jenner and M. Youdim, pp. 23-45. Academic Press, London (1996).
20. H. O. Sohn, H. B. Lim, Y. G. Lee, D. W. Lee and Y. T. Kim, Effect of subchronic administration of antioxidants against cigarette smoke exposure in rats. Arch. Toxicol. 67, 667-673 (1993).
21. V. Peltola, E. Mantyla, I. Huhtaniemi and M. Ahotupa, Lipid peroxidation and antioxidant enzyme activities in the rat testis after cigarette smoke inhalaltion or administration of polychlorinated biphenyls or polychlorinated naphthalenes. J. Androl. 15, 353-361 (1994).
22. H. Wurzel, C. C. Yen, C. Gairola and C. K. Chow, Oxidative damage and antioxidant status in the lungs and bronchoalveolar lavage fluid of rats exposed chronically to cigarette smoke. J. Biochem. Toxicol. 10, 11-17 (1995).
23. M. A. K. Markwell, S. M. Haas, L. L. Bieber and N. E. Tolbert, A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87, 206-210 (1978).
24. R. Soto-Otero, R. Riguera-Vega, E. Méndez-Álvarez, I. Sánchez-Sellero and M. López-Rivadulla Lamas, Interaction of 1,2,3,4-tetrahydroisoquinoline with some components of cigarette smoke: potential implications for Parkinson's disease. Biochem. Biophys. Res. Commun. 222, 607-611 (1996).
25. J. B. Clark, Electrochemical assay. In Enzyme Assays: a Practical Approach, ed. by R. Eisenthal and M. J. Danson, pp. 181-190. IRL Press, Oxford (1993).
26. H. Sakuma, M. Kusama, S. Munakata, T. Ohsumi and S. Sugawara, The distribution of cigarette smoke components between mainstream and sidestream smoke. I. Acidic components. Beitr. Tabakforsch. Int. 12, 63-71 (1983).
27. H. Sakuma, M. Kusama, K. Yamaguchi, T. Matsuki and S. Sugawara, The distribution of cigarette smoke components between mainstream and sidestream smoke. II. Bases. Beitr. Tabakforsch. Int. 12, 199-209 (1984).
28. H. Sakuma, M. Kusama, K. Yamaguchi and S. Sugawara, The distribution of cigarette smoke components between mainstream and sidestream smoke. III. Middle and higher boiling components. Beitr. Tabakforsch. Int. 12, 251-258 (1984).
29. M. E. Götz, G. König, P. Riederer and M. B. H. Youdim, Oxidative stress: free radical production in neuronal degeneration. Pharmacol. Ther. 63, 37-122 (1994).
30. M. Ebadi, S. K. Srinivasan and M. D. Baxi, Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 48, 1-19 (1996).
31. N. A. Simonian and J. T. Coyle, Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36, 83-106 (1996).
32. E. Méndez-Alvarez, R. Soto-Otero, I. Sanchez-Sellero and M. López Rivadulla Lamas, Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroiso-quinoline with components of cigarette smoke. Life Sci. 60, 1719-1727 (1997).